The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D07 | Corticosteroids, dermatological preparations | |
| 3 | D07A | Corticosteroids, plain | |
| 4 | D07AC | Corticosteroids, potent (group III) | |
| 5 | D07AC06 | Diflucortolone |
| Active Ingredient | Description | |
|---|---|---|
| Diflucortolone |
Diflucortolone is a topically acting fluoridated corticosteroid which suppresses inflammation in inflammatory and allergic skin conditions and alleviates the subjective complaints such as itching, burning and pain. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| NERISONE Cream, Ointment | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
